ArticleCancers2026

Neoadjuvant Immunotherapy for Hepatocellular Carcinoma Is Associated with Improved Survival After Hepatectomy: A Matched Analysis of the 2017 to 2022 National Cancer Database.

Lawrence Chiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.